Identification and quantification of 2′,3′-cAMP release by the kidney

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 3, 2009, Pages 855-865

  Ren, Jin ^a   Mi, Zaichuan ^a   Stewart, Nicolas A ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; ADENOSINE 2',3' PHOSPHATE; ADENYLATE CYCLASE; CYCLIC AMP; IODOACETIC ACID; ISOPRENALINE; MESSENGER RNA; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; KIDNEY; KIDNEY MASS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA DEGRADATION; TANDEM MASS SPECTROMETRY;

ADENINE NUCLEOTIDES; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; HYPERTENSION; KIDNEY; MALE; MASS SPECTROMETRY; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 62449261216     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.146712     Document Type: Article

References (40)

1. Akahane M, Ono H, Ohgushi H, and Takakura Y (2001a) Viability of ischemia/reperfused bone determined at the gene expression level. J Reconstr Microsurg 17:203-209.
2. Akahane M, Ono H, Ohgushi H, and Tamai S (2001b) Viability of ischemia/reperfused muscles in rat: a new evaluation method by UNA degradation. J Orthop Res 19:559-564.
3. Albig AR and Decker CJ (2001) The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae. Mol Biol Cell 12:3428-3438.
4. Almeida A, Paul Thiery J, Magdele′nat H, and Radvanyi F (2004) Gene expression analysis by real-time reverse transcription polymerase chain reaction: influence of tissue handling. Anal Biochem 328:101-108.
5. Banholzer R, Nair AP, Hirsch HH, Ming XF, and Moroni C (1997) Rapamyein destabilizes in.terleukin.-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3′ untranslated region. Mol Cell Biol 17:3254-3260.
6. Barber R and Butcher RW (1983) The egress of cyclic-AMP from metazoan cells. Adv Cyclic Nucleotide Res 15:119-138.
7. Borst P, de Wolf C, and van de Weterhig K (2007) Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch 453:661-673.
8. Broadus AE, Kaminsky NI, Northcutt RC, Hardman JG, Sutherland EW, and Liddle GW (1970) Effects of glucagon on adenosine 3′,5′- monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine. J Clin Invest 49:2237-2245.
9. Brunton LL and Mayer SE (1979) Extrusion of cAMP from pigeon erythrocytes. J Biol Chem 254:9714-9720.
10. Cheng J and Grande JP (20 07) Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp Biol Med 232:38-51.
11. Chiavegatti T, Costa VL Jr, Araújo MS, and Godinho RO (2008) Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway.[see comment]. Br J Pharmacol 153:1331-1340.
12. Cramer H and Lindl T (1974) Release of cyclic AMP from rat superior cervical ganglia after stimulation of synthesis in vitro. Nature 249:380-382.
13. Davoren PR and Sutherland EW (1963) The effect of L-epinephrine and other agents on the synthesis and release of adenosine 3′,5′-phosphate by whole pigeon erythrocytes. J Biol Chem 238:3009-3015.
14. Deeley RG, Westlake C, and Cole SPC (2006) Transmembrane transport of endo- and xenobiotics by mammalian ATP-bindmg cassette multidrug resistance proteins. Physiol Rev 86:849-899.
15. Doore BJ, Bashor MM, Spitzer N, Mawe RC, and Saier MH Jr (1975) Regulation of adenosine 3′,5′-monophosphate efflux from rat glioma cells in culture. J Biol Chem 250:4371-4372.
16. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (2001) Endogenous cyclic AMP- adenosine pathway regulates cardiac fibroblast growth. Hypertension 37:1095-1100.
17. Fan XC and Steitz JA (1998) Overexpression of HuR, anuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-contaming mRNAs. EMBO J 17: 3448-3460.
18. Fehr TF, Dickinson ES, Goldman SJ, and Slakey LL (1990) Cyclic AMP efflux is regulated by occupancy of the adenosine receptor in pig aortic smooth muscle cells. J Biol Chem 265:10974-10980.
19. 2-Adrenoceptors potentiate angiotensin II- and vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther 305:581-586.
20. Giron MC, Bin A, Brun P, Etteri S, Bolego C, Florio C, and Gaion RM (2008) Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP- adenosine pathway. Gastroenterology 134:1116-1126.
21. Hashemolhosseini S, Nagamine Y, Morley SJ, Desrivières S, Mercep L, and Ferrari S (1998) Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem 273:14424-14429.
22. Institute of Laboratory Animal Resources (1996) Guide for the Care and, Use of Laboratory Animals. 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
23. Jackson EK and Dubey RK (2001) Role of the extracellular cAMP-adenosine pathway in renal physiology. Am J Physiol 281:F597-F612.
24. Jackson EK and Mi Z (2000) Preglomerular microcirculation expresses the cyclic AMP-adenosine pathway. J Pharmacol Exp Ther 295:23-28.
25. Jackson EK, Mi Z, Zacharia LC, Tofovic SP, and Dubey RK (2007) The pancreato-hepatorenal cAMP-adenosine mechanism. J Pharmacol Exp Ther 321:799-809.
26. Jackson EK, Mi Z, Zhu C, and Dubey RK (2003) Adenosine biosynthesis in the collecting duct. J Pharmacol Exp Ther 307:888-896.
27. Jackson EK, Zacharia LC, Zhang M, Gillespie DG, Zhu C, and Dubey RK (2006) cAMP-adenosine pathway in the proximal tubule. J Pharmacol Exp Ther 317: 1219-1229.
28. Kather H (1990) Beta-adrenergic stimulation of adenine nucleotide catabolism and purine release in human adipocytes. J Clin Invest 85:106-114.
29. King CD and Mayer SE (1974) Inhibition of egress of adenosine 3′,5′-monophosphate from pigeon erythrocytes. Mol Pharmacol 10:941-953.
30. Klöss S, Rodenbach D, Bordel R, and Mülsch A (2005) Human-antigen R (HuR) expression in hypertension: downregulation of the mRNA stabilizing protein HuR in genetic hypertension. Hypertension 45:1200-1206.
31. Kruh GD, Zeng H, Rea PA, Liu G, Chen ZS, Lee K, and Belmsky MG (2001) MRP subfamily transporters and resistance to anticancer agents. J Bioenerg Biomembr 33:493-501.
32. Kuster J. Zapf J, and Jakob A (1973) Effects of hormones on cyclic AMP release in perfused rat livers. FEES Lett 32:73-77.
33. C, Krishnamurthy PC, Penmatsa H, Marrs KL, Wang XQ, Zaccolo M, Jalink K, Li M, Nelson DJ, Schuetz JD, et al. (2007) Spatio-temporal coupling of cAMP transporter to CFTR chloride channel function in the gut epithelia. Cell 131:940-951.
34. Markham R and Smith JD (1952) The structure of ribonucleic acid: I. Cyclic nucleotides produced by ribonuclease and by alkaline hydrolysis. Biochem J 52:552- 557.
35. O'Brien JA and Strange RC (1975) The release of adenosine 3′,5′-cyclic monophosphate from the isolated perfused rat heart. Biochem J 152:429-432.
36. Ren J, Mi ZC, and Jackson EK (2008) Assessment of nerve stimulation-induced release of purines from mouse kidneys by tandem mass spectrometry. J Pharmacol Exp Ther 325:920-926.
37. Thompson JE, Venegas FD, and Raines RT (1994) Energetics of catalysis by ribo-nucleases: fate of the 2′,3′-eyclic phosphodiester intermediate. Biochemistry 33: 7408-7414.
38. van Aubel RA, Smeets PH, Peters JG, Bindels HJ, and Russel FG (2002) The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 13:595-603.
39. Vyas SJ, Mi Z, and Jackson EK (1996) The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney. J Pharmacol Exp Ther 279:114-119.
40. Wilusz CJ, Wormington M, and Peltz SW (2001) The cap-to-tail guide to mKNA turnover. Na Rev Mol Cell Biol 2:237-246.